Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes

QR Code

Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes

Cátia Cristina Silva Sousa Vergara Palma,1 Pablo Moura Lopes,2 Eliete Leão Clemente Silva,1 Maria de Fátima da Matta Bevilaqua,1 Alfredo de Souza Bomfim,2 Marilia Brito Gomes1 1Department of Internal Medicine, Diabetes Unit, State University Hospital of Rio de Janeir...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Palma CCSSV, Lopes PM, Silva ELC, Bevilaqua MFM, Bomfim AS, Gomes MB
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2020
Sujets:	vascular age type 2 diabetes cardiovascular risk cimt Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/e6f704fee2be4a0c8c287fceb23e7957
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout
par: Gancheva R., et autres
Publié: (2019)

Attainment of recommended therapeutic targets of modifiable cardiovascular risk factors among individuals with type 2 diabetes mellitus screened at a diabetes clinic in Sri Lanka
par: Weerarathna TP, et autres
Publié: (2018)

Ideal Cardiovascular Health and Vascular Phenotype Associations in Mothers with Obesity and Their Six-Year-Old Children
par: Litwin L, et autres
Publié: (2021)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
par: McIntyre HD
Publié: (2010)

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
par: Avgerinos I, et autres
Publié: (2019)

Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis
par: Huang H, et autres
Publié: (2018)

Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
par: Hinnen D, et autres
Publié: (2019)

Relationship Between Skeletal Muscle Mass to Visceral Fat Area Ratio and Cardiovascular Risk in Type 2 Diabetes
par: Liu D, et autres
Publié: (2021)

The Epidemic Of The Metabolic Syndrome Among The Palestinians In The Gaza Strip
par: Jamee AS, et autres
Publié: (2019)

Cardiovascular Safety and Superiority of Anti-Obesity Medications
par: Alobaida M, et autres
Publié: (2021)

Assessment of Cardiovascular Risk Factors and Their Interactions in the Risk of Coronary Heart Disease in Patients with Type 2 Diabetes with Different Weight Levels, 2013–2018
par: Wang C, et autres
Publié: (2021)

Clinical utility of metabolic syndrome severity scores: considerations for practitioners
par: DeBoer MD, et autres
Publié: (2017)

Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes
par: Latika Sibal, et autres
Publié: (2011)

The Challenges of Identifying Environmental Determinants of Type 1 Diabetes: In Search of the Holy Grail
par: Butalia S, et autres
Publié: (2020)

An introduction to therapeutic approaches to vascular cognitive impairment
par: Atticus H Hainsworth, et autres
Publié: (2021)

The Mental Status in Patients with Diabetes Mellitus Admitted to a Diabetes Clinic After Presenting in the Emergency Room: The Application of the SCL-90 Scale
par: Albai O, et autres
Publié: (2021)

Optimal Body Fat Percentage Cut-Off Values in Predicting the Obesity-Related Cardiovascular Risk Factors: A Cross-Sectional Cohort Study
par: Macek P, et autres
Publié: (2020)

Management Practice and Contributing Risk Factors for Chronic Complications Among Type 2 Diabetes Mellitus Adult Patients in Follow-Up at a Tertiary Care Teaching Hospital
par: Negash Z, et autres
Publié: (2020)

Impacts of Pre-Diabetes or Prehypertension on Subsequent Occurrence of Cardiovascular and All-Cause Mortality among Population without Cardiovascular Diseases
par: Huang Y, et autres
Publié: (2020)

Scutellaria barbata D. Don Polysaccharides Inhibit High Glucose-Induced Proliferation and Angiogenesis of Retinal Vascular Endothelial Cells
par: Li W, et autres
Publié: (2021)

Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes
par: Malloy J, et autres
Publié: (2012)

Magnitude of, and Factors Associated with Cardiovascular Disease Among Type Two Diabetes Mellitus Patients
par: Tesfaye A, et autres
Publié: (2020)

Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication
par: Dessie G, et autres
Publié: (2021)

Potential role of phytochemicals in metabolic syndrome prevention and therapy
par: Francini-Pesenti F, et autres
Publié: (2019)

Incremental increases in economic burden parallels cardiometabolic risk factors in the US
par: McQueen RB, et autres
Publié: (2016)

Derivation and Validation of a Prediction Model for Predicting the 5-Year Incidence of Type 2 Diabetes in Non-Obese Adults: A Population-Based Cohort Study
par: Cai XT, et autres
Publié: (2021)

Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
par: Zhao H, et autres
Publié: (2019)

Depression Among Patients with Type 2 Diabetes Mellitus: Prevalence and Associated Factors in Hue City, Vietnam
par: Tran NMH, et autres
Publié: (2021)

Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk
par: Togfano RJ, et autres
Publié: (2020)

Developmental origins of health and disease: a new approach for the identification of adults who suffered undernutrition in early life
par: Ferreira HS, et autres
Publié: (2018)

Nomogram Model for Screening the Risk of Type II Diabetes in Western Xinjiang, China
par: Wang Y, et autres
Publié: (2021)

Association Between Early Markers of Renal Injury and Type 2 Diabetic Peripheral Neuropathy
par: Yang Z, et autres
Publié: (2021)

Comparison of the Incidence of Cardiovascular Diseases in Weight Groups with Healthy and Unhealthy Metabolism
par: Wang W, et autres
Publié: (2021)

Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
par: Cosenso-Martin LN, et autres
Publié: (2020)

Exosomes from β-cells alleviated hyperglycemia and enhanced angiogenesis in islets of streptozotocin-induced diabetic mice
par: Sun Y, et autres
Publié: (2019)

Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks
par: Shemesh E, et autres
Publié: (2019)

Assessment of Cardiovascular Risk Factors in Patients with Type 2 Diabetes in Upper Egypt Villages
par: Hussein A, et autres
Publié: (2020)

Cardiovascular Risk Prediction, Glycemic Control, and Determinants in Diabetic and Hypertensive Patients in Massawa Hospital, Eritrea: Cross-Sectional Study on 600 Subjects
par: Tesfai B, et autres
Publié: (2021)

Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel
par: Bojko Bjelakovic, et autres
Publié: (2021)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
par: Peter J Donovan, et autres
Publié: (2010)